Genentech alum Jane Grogan goes startup hopping from ArsenalBio to Graphite Bio; Scott Holmes to handle CFO duties at Catamaran Bio, teaming up again with ex-Disarm CEO
→ Gene editing player Graphite Bio notched a $150 million Series B megaround to boost its total to $195 million, and a month later …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
